Header cover image
  • Investing Ideas
  • Dutch Pharmaceuticals & Biotech Top Stock Picks from Analysts

Dutch Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

1

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Vivoryon Therapeutics

Market Cap: €33.3m

Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.

VVY

€1.13

7D

-8.5%

1Y

-19.8%